A Framework for Payer Assessment of the Value of New Technologies: A US Approach

Office of Health Economics

Seminar Briefing from Office of Health Economics

Abstract: Dr Steven Pearson has convened a US policy workgroup of payers, drug and device manufacturers, patients' groups, and clinician specialty societies to help develop a “value framework”. Payers in the US do not embrace a single, dominant method for determining the value of new technologies. With this mind, Dr Steven Pearson has convened a US policy workgroup of payers, drug and device manufacturers, patients' groups, and clinician specialty societies to help develop a “value framework” to guide the assessment of drugs and devices in the US. In this Briefing, based on an OHE lunchtime seminar, he presents an early draft version of this framework as a method for integrating elements of cost-effectiveness and affordability.

Keywords: A; Framework; for; Payer; Assessment; of; the; Value; of; New; Technologies:; A; US; Approach (search for similar items in EconPapers)
JEL-codes: I1 (search for similar items in EconPapers)
Date: 2015-03-01
References: Add references at CitEc
Citations: View citations in EconPapers (2)

Downloads: (external link)
https://www.ohe.org/publications/framework-payer-a ... -payer-assessment-2/ (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:ohe:sembri:001589

Access Statistics for this paper

More papers in Seminar Briefing from Office of Health Economics Contact information at EDIRC.
Bibliographic data for series maintained by Publications Manager ( this e-mail address is bad, please contact ).